An interventional study of Omega-3 Enriched Eggs and nutrition education in Maternal and Neonatal Outcomes, Pregnancy and Malnutrition Pregnancy, sponsored by Institut Pertanian Bogor. Active, not recruiting at 1 site in Indonesia. Open to female participants aged 20 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Institut Pertanian Bogor · Not applicable, Interventional, and Prevention
The goal of this clinical trial is to evaluate the effect of omega-3 enriched egg supplementation combined with nutrition education in pregnant women with Chronic Energy Deficiency (CED).
The main questions it aims to answer are:
Researchers will compare the intervention group (receiving omega-3 enriched eggs and nutrition education) to a control group (receiving nutrition education only) to evaluate these effects.
Participants will:
1,277 studies on the registry are indexed under Malnutrition; 230 are open to participants now.
This study's enrollment of 42 is below the median of 118 across 843 interventional studies indexed under Malnutrition.
Browse Malnutrition studies →Institut Pertanian Bogor is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in this group receive daily omega-3 enriched eggs combined with structured nutrition education sessions.
Dietary Supplement: Omega-3 Enriched Eggs · Behavioral: nutrition education
Participants in this group receive standard nutrition education only, without omega-3 egg supplementation.
Behavioral: nutrition education
Participants will be provided with 2 omega-3 enriched eggs per day to consume daily throughout the study intervention period.
Participants will attend structured nutrition education sessions focusing on the importance, sources, and benefits of omega-3 fatty acids during pregnancy for maternal and fetal health.
Maternal Serum DHA Level (ug/mL)
Evaluated via maternal blood serum analysis to measure changes in docosahexaenoic acid (DHA) concentrations before and after intervention, using Gas Chromatography (GC).
Time frame: Baseline (Day 0) and 10 weeks post-intervention
Newborn Birth Weight (gram)
Weight of the newborn measured using a calibrated digital infant scale within 24 hours of delivery.
Time frame: At delivery (within 24 hours post-birth)
Maternal serum EPA level (ug/mL)
Changes of maternal serum EPA level before and after intervention, using Gas Chromatography (GC).
Time frame: Baseline (Day 0) and 10 weeks post-intervention
Newborn Birth Length (cm)
Length of the newborn measured from the top of the head to the heel using a standardized infantometer within 24 hours of delivery.
Time frame: At delivery (within 24 hours post-birth)
Newborn Head Circumference (cm)
Maximum occipitofrontal circumference of the newborn measured using a non-stretchable measuring tape within 24 hours of delivery.
Time frame: at delivery (within 24 hours post-birth)
Maternal Serum Albumin Level (g/dL)
Concentration of albumin in maternal blood serum measured post-intervention or at delivery to evaluate maternal protein nutritional status.
Time frame: Baseline (Day 0) and 10 weeks post-intervention
Gestational Age at Delivery
Recorded in completed weeks and days at the time of delivery, determined by early ultrasound examination or last menstrual period (LMP). Unit of Measure: Weeks
Time frame: At delivery
Incidence of Preterm Delivery
Proportion of live births occurring prior to 37 completed weeks of gestation.
Time frame: At delivery
Breast Milk Docosahexaenoic Acid (DHA) Level
Concentration of DHA in breast milk samples collected post-partum, expressed as a percentage of total fatty acids, analyzed using gas chromatography.
Time frame: At 7 to 14 day postpartum
Maternal Serum Ferritin Levels (ng/mL)
Concentration of ferritin in maternal blood serum measured post-intervention or at delivery to evaluate maternal iron storage levels.
Time frame: Baseline (Day 0) and 10 weeks post-intervention
Plan to share: No — Individual participant data will not be shared to protect participant confidentiality and privacy, as explicit consent for public data sharing was not obtained during the informed consent process.
No publications or documents are linked to this record.
Started May 2026 (actual). Primary completion is estimated for Nov 2026, 6 months after the start.
Of 392 non-industry interventional studies with no phase under Malnutrition, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 6 months is below that.
Counting every sponsor, half of 418 studies reached it within 22 months; a quarter within 11 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut Pertanian Bogor